KLK3 and Familial prostate cancer: In many settings PSA screening has contributed to enhanced detection, diagnosis and treatment of prostate cancer, but it is a contentious issue owing to the potential for over-diagnosis and over-treatment of prostate cancers that may not become clinically significant during the lifetime of the patient.